loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 206367 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 AMLODIPINE BESYLATE (3)

filter

01 INVAGEN PHARMS (3)

filter

01 TABLET;ORAL (3)

filter

01 EQ 10MG BASE (1)

02 EQ 2.5MG BASE (1)

03 EQ 5MG BASE (1)

filter

01 USA (3)

URL Supplier Web Content
TABLET;ORAL
EQ 5MG BASE
AMLODIPINE BESYLATE
USA
206367
2015-12-10
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
EQ 10MG BASE
AMLODIPINE BESYLATE
USA
206367
2015-12-10
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
EQ 2.5MG BASE
AMLODIPINE BESYLATE
USA
206367
2015-12-10
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 206367

Looking for CTD TGA MCC DOSSIER APPLICATION 206367 3

19

InvaGen Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is AMLODIPINE BESYLATE, with a corresponding application number 206367 and regulatory information .

proudly manufactured in the

approval since 2015-12-10

InvaGen Pharmaceuticals Inc's AMLODIPINE BESYLATE TABLET;ORAL, medication with EQ 5MG BASE of AMLODIPINE BESYLATE.

18

InvaGen Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is AMLODIPINE BESYLATE, with a corresponding application number 206367 and regulatory information .

proudly manufactured in the

approval since 2015-12-10

InvaGen Pharmaceuticals Inc's AMLODIPINE BESYLATE TABLET;ORAL, medication with EQ 10MG BASE of AMLODIPINE BESYLATE.

17

InvaGen Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is AMLODIPINE BESYLATE, with a corresponding application number 206367 and regulatory information .

proudly manufactured in the

approval since 2015-12-10

InvaGen Pharmaceuticals Inc's AMLODIPINE BESYLATE TABLET;ORAL, medication with EQ 2.5MG BASE of AMLODIPINE BESYLATE.

Post Enquiry
POST ENQUIRY